# American Vanguard Corp: Form 10-Q for the period ended Sep 30, 2014

- Company: [American Vanguard Corp](/companies/avd.md) (CIK 5981)
- Form: 10-Q
- Filed: 2014-10-31
- Accepted by EDGAR: Oct 31, 2014, 14:01 ET
- Period: 2014-09-30
- Accession: 0001193125-14-391725
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/5981/000119312514391725/d797424d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/5981/000119312514391725/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $71.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $221.0m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $43.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $137.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2014-07-01 to 2014-09-30 | $28.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-01-01 to 2014-09-30 | $83.3m | us-gaap:GrossProfit |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | $1.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | $6.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $804.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $2.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $856.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | $732.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $3.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $0.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 28,797,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 28,888,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | −$33.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $4.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2014-01-01 to 2014-09-30 | $1.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-09-30 | $5.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $291.5m | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $482.0m | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $100.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-09-30 | $222.1m | us-gaap:Liabilities |
| Long-term debt | at 2014-09-30 | $95.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-09-30 | $71.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-09-30 | $260.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 36,327 characters.

### FORWARD-LOOKING STATEMENTS/RISK FACTORS:

The Company, from time-to-time, may discuss forward-looking statements including assumptions concerning the Company’s operations, future results and prospects. These forward-looking statements are based on current expectations and are subject to a number of risks, uncertainties and other factors. In connection with the Private Securities Litigation Reform Act of 1995, the Company provides the following cautionary statements identifying important factors which, among other things, could cause the actual results and events to differ materially from those set forth in or implied by the forward-looking statements and related assumptions contained in the entire Report. Such factors include, but are not limited to: product demand and market acceptance risks; the effect of economic conditions; weather conditions; changes in regulatory policy; the impact of competitive products and pricing; changes in foreign exchange rates; product development and commercialization difficulties; capacity and supply constraints or difficulties; availability of capital resources; general business regulations, including taxes and other risks as detailed from time-to-time in the Company’s reports and filings filed with the U.S. Securities and Exchange Commission (the “SEC”). It is not possible to foresee or identify all such factors. For more detailed information, refer to Item 1A., Risk factors and Item 7A., Quantitative and Qualitative Disclosures about Market Risk, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

### RESULTS OF OPERATIONS

### Quarter Ended September 30:

| Net sales: | 2014 | 2013 | Change |
| --- | ---: | ---: | ---: |
| Insecticides | $24,626 | $49,539 | $(24,913) |
| Herbicides/soil fumigants/fungicides | 29,363 | 28,880 | 483 |
| Other, including plant growth regulators | 10,711 | 9,189 | 1,522 |
| Total crop | 64,700 | 87,608 | (22,908) |
| Non-crop | 6,935 | 9,593 | (2,658) |
|  | $71,635 | $97,201 | $(25,566) |
| Cost of sales: |  |  |  |
| Insecticides | $14,466 | $28,700 | $(14,234) |
| Herbicides/soil fumigants/fungicides | 17,084 | 15,742 | 1,342 |
| Other, including plant growth regulators | 7,375 | 4,715 | 2,660 |
| Total crop | 38,925 | 49,157 | (10,232) |
| Non-crop | 4,417 | 4,885 | (468) |
|  | $43,342 | $54,042 | $(10,700) |
| Gross margin: |  |  |  |
| Insecticides | $10,160 | $20,839 | $(10,679) |
| Herbicides/soil fumigants/fungicides | 12,279 | 13,138 | (859) |
| Other, including plant growth regulators | 3,336 | 4,474 | (1,138) |
| Gross margin crop | 25,775 | 38,451 | (12,676) |
| Gross margin non-crop | 2,518 | 4,708 | (2,190) |
|  | $28,293 | $43,159 | $(14,866) |
| Gross margin crop | 40% | 44% |  |
| Gross margin non-crop | 36% | 49% |  |
| Total gross margin | 40% | 44% |  |
|  | **2014** | **2013** | **Change** |
| Net sales: |  |  |  |
| US | $54,552 | $79,425 | $(24,873) |
| International | 17,083 | 17,776 | (693) |
|  | $71,635 | $97,201 | $(25,566) |

Our overall financial performance including net sales and net income for the quarter ended September 30, 2014 declined as compared to the same period in 2013. Our net sales for the period were down 26% to $71,635 compared to $97,201 for the third quarter of 2013. Further, net income attributable to American Vanguard was down to $732 as compared to $8,870 for the same period in 2013. Net sales for our Crop products were down by approximately 26%, while net sales for Non-Crop products were down by about 28% for the comparable period. A more detailed discussion of general market conditions and sales performance by category of products appears below.

Overall sales performance declined in the current quarter, primarily resulting from reduced purchases of the Company’s granular soil insecticides. As has been noted in previous filings, inclement Midwest weather, during the spring planting season of 2013, resulted in reduced use of these products in the U.S. corn market. Nevertheless, our customers continued to purchase these soil insecticides through the third quarter of 2013, before realizing the extent of excess inventory accumulating throughout the distribution channel. Thereafter, beginning in the fourth quarter of 2013 and continuing through the first three quarters of 2014, restocking orders have been down sharply, as carryover inventories in the distribution channel continue to be reduced. Quarterly sales in both our Herbicide and Other product categories were higher than the prior year period as detailed below.

Net sales of our insecticides as a group were down about 50% during the third quarter of 2014. Within these products, net sales of our granular soil insecticide products (“GSIs”) were down approximately 47% as compared to the same period of the prior year due largely to lower sales of our Force®SmartBox and Aztec® products. Sales of non-corn insecticide products Thimet®, Nemacur®, and Bidrin® also posted a lower quarterly performance. Most of the remaining products in this category had fairly similar year-over-year sales performance.

Within the group of herbicides/fungicides/fumigants, net sales for the third quarter of 2014 increased by approximately 2% to $29,363 from $28,880, during the comparable period of 2013. Net sales of our herbicide products were down overall with somewhat lower sales of our post-emergent corn herbicide Impact® offset by higher sales of Dacthal®. We saw small increases in net sales of our soil fumigants and our fungicides during the period.

Within the group of other products (which includes plant growth regulators, molluscicides and tolling activity), our net sales increased by about 16% as compared to those in the third quarter of 2013. This increase was driven by higher sales of our cotton harvest defoliant Folex®. Increased U.S. cotton acreage in 2014 and favorable autumn harvest weather facilitated this improvement. Increased sales of Folex was somewhat offset by slight decline in granules and toll manufacturing.

Our non-crop sales ended the third quarter of 2014 at $6,935 as compared to $9,593 for the same period of the prior year. This change was due largely to reduced sales of our mosquito control adulticide Dibrom® due to lack of Gulf Coast hurricane activity, partially offset by improvement in year-over-year sales of our Pest Strip products for commercial pest control and the Envance products for consumer pest control. As mentioned above, limited hurricane activity along the U.S. Gulf Coast region dampened seasonal demand for Dibrom. Finally, our PCNB fungicide sales improved slightly from the prior year’s third quarter as this product continues its gradual sales/market share recovery from a stop sale order in 2011.

Our cost of sales for the third quarter of 2014 was $42,342 or 60% of net sales. This compared to $54,042 or 56% of net sales for 2013. The Company aggregates a number of key variable, semi-variable and fixed cost components within reported cost of sales. The two major cost components are raw materials (including subcontract costs) and factory operating costs. During the quarter, our raw material costs decreased by 26%, which was consistent with the reduction in sales. Our factory expenses were down by approximately 8% year-over-year, as we focused on reducing costs. However, in light of higher-than-normal inventory levels for certain corn products both in the distribution channel and at the Company, we made the decision to reduce output resulting in reduced manufacturing activity. With materially lower plant activity and slightly lower plant costs, we incurred an increase in unabsorbed factory expenses as compared to the comparable quarter.

For the three month period ended September 30, 2014, gross profit declined by $14,866 to end at $28,293, as compared to gross profit for the same period of the prior year. That reduction resulted from lower sales and increased unabsorbed factory costs. Lower sales accounted for 84% of the decline, and increased unabsorbed factory costs accounted for the balance.

Gross margin percentage for the third quarter of 2014 declined by 4% and ended at 40%, as compared to 44% for the same period of the prior year. The percentage margin is unaffected by lower sales volume and is driven by a combination of product net selling prices, changes in product mix as well as increases in manufacturing costs related to unabsorbed factory fixed costs. Unabsorbed factory costs accounted for three quarters of the margin percent decline, with the balance due to the net selling price and mix of product sold.

It should be noted that, when making comparisons with other companies’ financial statements, the Company reports distribution costs in operating expenses and not as part of cost of sales.

Operating expenses decreased by $1,356 to $26,669 for the three months ended September 30, 2014 as compared to the same period in 2013. The differences in operating expenses by department are as follows:

|  | 2014 | 2013 | Change |
| --- | ---: | ---: | ---: |
| Selling | $7,067 | $7,419 | $(352) |
| General and administrative | 6,656 | 7,576 | (920) |
| Research, product development and regulatory | 5,200 | 5,102 | 98 |
| Freight, delivery and warehousing | 7,746 | 7,928 | (182) |
|  | $26,669 | $28,025 | $(1,356) |

20

- Selling expenses decreased by approximately 5% over the comparable quarter of the prior year. The main driver for the decrease is cost control across a range of expenses including reduced travel and costs incurred operating our foreign subsidiaries.
- General and administrative expenses decreased by about 12% quarter over quarter. The main drivers for the decrease are primarily due to reduced incentive compensation, lower legal costs and the recognition of other income in the dilution of our investment in TyraTech.
- Research, product development costs and regulatory expenses increased by about 2% over the comparable three month period. This is as a result of our continuing drive to build our business through product innovation.
- Freight, delivery and warehousing costs decreased by about 2%, driven primarily as a result of lower sales, offset by strong domestic sales of our high volume fumigants products and continued growth of our international business. As a percentage of sales, freight ended at 10.8% of sales for the three months ended September 30, 2014 as compared to 8.1% for the same period of the prior year.

We continue to review operating costs and will make reductions in expenses as appropriate.

Interest costs net of capitalized interest, were $779 in the three months to September 30, 2014 as compared to $444 in the same period of 2013. Interest costs are summarized in the following table:

### Average Indebtedness and Interest expense

|  | Q3 2014 Average Debt | Interest Expense | Interest Rate | Q3 2013 Average Debt | Interest Expense | Interest Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Working capital revolver | 94,935 | 613 | 2.6% | 40,728 | 355 | 3.5% |
| Other notes payable | 152 | 1 | 0.0% | 224 | 2 | 3.3% |
| Capitalized interest | — | (25) | — | — | (20) | — |
| Amortization of deferred loan fees | — | 106 | — | — | 55 | — |
| Amortization of other deferred liabilities | — | 74 | — | — | 44 | — |
| Other interest expense | — | 10 | — | — | 8 | — |
| Adjusted average indebtedness | $95,087 | $779 | 3.3% | $40,952 | $444 | 4.4% |

The Company’s average overall debt for the three months ended September 30, 2014 was $95,087 as compared to $40,952 for the three months ended September 30, 2013. Furthermore, during the three months to September 30, 2014, we incurred non-cash costs related to amortization of discounting for deferred payments and other interest expense, net of capitalized interest, in the amount of $166 as compared to $89 for the same period of the prior year. As can be seen from the table above, the effective rate on our bank borrowings was 2.6% for the period to September 30, 2014, as compared to 3.5% for the same period of the prior year. Our overall effective interest rate was 3.3% for the three months ended September 30, 2014, as compared to 4.4% at September 30, 2013.

Income tax expense has reduced by $5,559 to end at $0 for the three months ended September 30, 2014 as compared to $5,559 for the comparable period in 2013. The effective tax rate for the quarter was 0.0% as compared to 37.8% in the same period of the prior year. The decrease in the rate is primarily driven by the ratio of projected domestic sourced income in relation to foreign sourced income and a $328 discrete item related to the release of an income tax reserve in the current quater. The release of the income tax reserve resulted from the lapse of a statute for a tax year in which the Company is no longer subject to examination. The tax rate is based on management’s estimate of the full year income tax rate and is subject to ongoing review and revision.

Our overall net income for the three months ended September 30, 2014 decreased to $732 or $0.03 per diluted share as compared to $8,870 or $0.31 per diluted share in the same quarter of 2013.

### Nine Months Ended September 30:

| Net sales: | 2014 | 2013 | Change |
| --- | ---: | ---: | ---: |
| Insecticides | $105,587 | $167,624 | $(62,037) |
| Herbicides/soil fumigants/fungicides | 66,220 | 86,565 | (20,345) |
| Other, including plant growth regulators | 23,447 | 26,108 | (2,661) |
| Total crop | 195,254 | 280,297 | (85,043) |
| Non-crop | 25,789 | 25,202 | 587 |
|  | $221,043 | $305,499 | $(84,456) |
| Cost of goods sold: |  |  |  |
| Insecticides | $66,117 | $94,203 | $(28,086) |
| Herbicides/soil fumigants/fungicides | 39,490 | 45,789 | (6,299) |
| Other, including plant growth regulators | 16,899 | 13,097 | 3,802 |
| Total crop | 122,506 | 153,089 | (30,583) |
| Non-crop | 15,279 | 13,404 | 3,805 |
|  | $137,785 | $166,493 | $(28,778) |
| Gross margin: |  |  |  |
| Insecticides | $39,470 | $73,421 | $(33,951) |
| Herbicides/soil fumigants/fungicides | 26,730 | 40,776 | (14,046) |
| Other, including plant growth regulators | 6,548 | 13,011 | (6,463) |
| Gross margin crop | 72,748 | 127,208 | (54,460) |
| Gross margin non-crop | 10,510 | 11,798 | (1,288) |
|  | $83,258 | $139,006 | $(55,748) |
| Gross margin crop | 37% | 45% |  |
| Gross margin non-crop | 41% | 47% |  |
| Total gross margin | 38% | 45% |  |
|  | **2014** | **2013** | **Change** |
| Net sales: |  |  |  |
| US | $162,602 | $250,367 | $(87,765) |
| International | 58,441 | 55,132 | 3,309 |
|  | $221,043 | $305,499 | $(84,456) |

Overall financial performance including net sales and net income for the nine month period ended September 30, 2014 declined as compared to the same period in 2013. Net sales for the period were down approximately 28% to $221,043 compared to $305,499 for the first nine months of 2013. Further, net income attributable to American Vanguard reduced to $3,036 as compared to $34,171, for the same period in 2013. Net sales for our crop business were down by approximately 30%, while net sales for non-crop products were up by about 2% for the comparable period. A more detailed discussion of general market conditions and sales performance by category of products appears below.

As has been noted in previous filings, inclement Midwest weather, during the spring planting season of 2013, resulted in reduced use of our products in the U.S. corn market. Nevertheless, our customers continued to purchase these soil insecticides through the third quarter of 2013, before realizing the extent of excess inventory accumulating throughout the distribution channel. Thereafter, beginning in the fourth quarter of 2013 and continuing through the first three quarters of 2014, restocking orders have been down sharply, as customers continued to draw down carryover inventories. At the conclusion of the reporting period, inventory levels in the distribution channel were much closer to the historical average. In most of the other crops that we serve, such as potatoes, cotton, peanuts, sugarcane, our product sales are performing comparable to those sales in the same period of prior year. Additional details are provided below.

Net sales of our insecticides as a group were down about 37% at $105,587, during the first nine months of 2014, as compared to $167,624 during the same period of the prior year. Within these products, net sales of our granular soil insecticides (“GSIs”) were down approximately 41% from the comparable period in 2013. Most of our GSI brands contributed to this decrease. In contrast, Thimet, used in peanuts and sugarcane, saw a year-over-year sales increase; as did our Mocap and Nemacur products that are largely sold in international markets. Net sales of our non-GSI insecticides declined by approximately 11%, during the first nine months of 2014, mainly due to lower year-over-year sales of Dibrom which is used in citrus crops to effectively combat pshyllids, while most other products in the non-GSI category improved slightly.

Within the group of herbicides/fungicides/fumigants, net sales for the first three quarters of 2014 were down by 23% compared to the first nine months of 2013. This decrease was largely driven by reduced sales of our herbicide product Impact as excess inventories in the distribution channels have been worked down. We continue to experience solid demand for our soil fumigants which rose more than 5% during the first nine months of the 2014, despite some challenging Western U.S. drought conditions. Our primary fungicide PCNB, used in potatoes, continues a gradual market share recovery by posting a greater than 84% increase over prior year-to-date sales.

Within the group of other products (which includes plant growth regulators, molluscicides and tolling activity), our net sales decreased by about 10% as compared to those in the nine months of 2013. This results from the year-to-date sales declines in NAA and Metaldehyde products offset by gains in 2014 sales of our SmartBlock potato sprout inhibitor.

Our non-crop sales for the first nine months of 2014 were $25,789, as compared to $25,202 for the same period of the prior year. Sales of our mosquito adulticide Dibrom® are down about 25% year-to-date, due in part to lighter storm conditions in both the Mid-Atlantic and Southeast regions. Sales of our PCNB fungicide for turf applications were up 7%, as compared to the same period of the prior year, as we endeavor to recapture our turf applications market position after experiencing very limited sales in 2011 due to a temporary stop sale order.

Our cost of sales for the first nine months of 2014 was $137,785 or 62% of net sales, compared to $166,493 or 55% of net sales for 2013. The Company aggregates a number of key variable, semi-variable and fixed cost components within reported cost of sales. The two major cost components are raw materials (including sub contract costs) and factory operating costs. During the nine month period, our raw material costs decreased by 26%, which is broadly consistent with the reduction in our reported net sales. Our factory expenses were down by approximately 8% year-over-year, as we focused on reducing costs. However, in light of higher-than-normal inventory levels for certain corn products both in the distribution channel and at the Company, we made the decision to reduce output and, by implication, manufacturing activity. With materially lower plant activity and slightly lower plant costs, we incurred an increase in unabsorbed factory expenses as compared to the same period of the prior year.

For the nine month period ended September 30, 2014, gross profit declined by $55,748 to end at $83,258, as compared to gross profit for the same period of the prior year. That reduction resulted from lower sales and increased unabsorbed factory costs. Lower sales accounted for 79% of the decline, and increased unabsorbed factory costs accounted for the balance.

Gross margin percentage for the first nine months of 2014 declined by 7% and ended at 38%, as compared to 45% for the same period of the prior year. The percentage margin is unaffected by lower sales volume and is driven by a combination of product net selling prices, changes in product mix as well as increases in manufacturing costs related to unabsorbed factory fixed costs. Unabsorbed factory costs accounted for 6% of the margin percent decline, with the other 1% decline due to net selling price and mix of products sold.

It should be noted that, when making comparisons with other companies’ financial statements, the Company reports distribution costs in operating expenses and not as part of cost of sales.

Operating expenses decreased by $7,874 to $76,949 for the nine months ended September 30, 2014 as compared to the same period of 2013. The differences in operating expenses by department are as follows:

|  | 2014 | 2013 | Change |
| --- | ---: | ---: | ---: |
| Selling | $24,043 | $23,101 | $942 |
| General and administrative | 19,198 | 27,747 | (8,549) |
| Research, product development and regulatory | 14,973 | 14,714 | 259 |
| Freight, delivery and warehousing | 18,735 | 19,261 | (526) |
|  | $76,949 | $84,823 | $(7,874) |

23

- Selling expenses for the period increased by about 4% over the comparable period. The main driver for the increase is costs associated with servicing our growing international operations, domestic field stewardship activities, and advertising and promotion costs.
- General and administrative expenses decreased by about 31% over the same period of 2013. The main drivers for the decrease are primarily due to reduced incentive compensation, lower legal costs, recognition of other income in the dilution of our investment in TyraTech, and lower third party consulting costs associated with the creation of our international subsidiary structure in 2013.
- Research, product development costs and regulatory expenses increased by about 2% when compared to the same period of 2013. This is as a result of increased staffing in our business development offset by timing and mix of external regulatory studies.
- Freight, delivery and warehousing costs for the nine months ended September 30, 2014 were $18,735 or 8.4% of sales as compared to $19,261 or 6.3% of sales for the same period in 2013. As a percentage of sales, freight costs rose during the period due proportionately higher sales of products having greater costs including soil fumigants and international goods.

We continue to review operating costs and will make reduction as appropriate.

Interest costs net of capitalized interest, were $2,236 in the nine months of 2014 as compared to $1,467 in the same period of 2013. Interest costs are summarized in the following table:

### Average Indebtedness and Interest expense

|  | Nine months ended September 30, 2014 Average Debt | Interest Expense | Interest Rate | Nine months ended September 30, 2013 Average Debt | Interest Expense | Interest Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Term loan | $0 | $0 | 0.0% | $31,177 | $880 | 3.7% |
| Working capital revolver | 94,135 | 1,786 | 0.0% | 24,967 | 544 | 2.9% |
| Average | 94,135 | 1,786 | 2.5% | 56,144 | 1,424 | 3.4% |
| Other notes payable | 169 | 4 | 0.0% | 292 | 6 | 2.7% |
| Capitalized interest | — | (56) | — | — | (245) | — |
| Amortization of deferred loan fees | — | 223 | — | — | 125 | — |
| Amortization of other deferred liabilities | — | 248 | — | — | 130 | — |
| Other interest expense | — | 31 | — | — | 27 | — |
| Adjusted average indebtedness | $94,304 | $2,236 | 2.4% | $56,436 | $1,467 | 3.5% |

The Company’s average overall debt for the nine months ended September 30, 2014 was $94,304 as compared to $56,436 for the same period of 2013. Furthermore, during the nine months ended September 30, 2014, we incurred non-cash costs related to amortization of discounting of deferred payments and other interest expense in the amount of $450 as compared to $43 for the same period of the prior year. As can be seen from the table above, the effective rate on our bank borrowings was 2.5% for the period to September 30, 2014, as compared to 3.4% for the same period of the prior year. Our overall effective interest rate was 2.4% for the nine months ended September 30, 2014, as compared to 3.5% in the same period of 2013.

Income tax expense has decreased by $17,644 to end at $856 for the nine months ended September 30, 2014, as compared to $18,500 for the comparable period in 2013. The effective tax rate for the nine months ended September 30, 2014 is 21%, as compared to 35% in the same period of the prior year. The reduction in the rate is primarily driven by the ratio of projected domestic sourced income in relation to foreign sourced income and a $328 discrete item related to the release of an income tax reserve in the current quarter. The release of the income tax reserve resulted from the lapse of a statue for a tax year in which the Company is no longer subject to examination. The tax rate is based on management’s estimate of the full year income tax rate and is subject to ongoing review and revision.

Our overall net income attributable to American Vanguard for the nine months of 2014 was $3,036 or $0.11 per diluted share, as compared to $34,170 or $1.18 per diluted share in the same period of 2013.

#### LIQUIDITY AND CAPITAL RESOURCES

The Company used $33,836 of cash in operating activities during the nine months ended September 30, 2014. This compared to $7,200 of cash generated in the same period of last year. Net income of $2,584, non-cash depreciation, amortization of intangibles, other assets and discounted future liabilities in the amount of $16,577, stock based compensation expense of $3,046 plus a non cash net gain recorded on our equity investment provided a net cash inflow of $21,623 as compared to $51,343 for the same period last year.

Accounts receivables ended at $89,287 as compared to $74,060 at the start of the year. This increase in trade receivable of $15,227 is consistent with similar increases in prior years and reflects the commencement of the new season. In addition, other receivables increased by $1,768 primarily related to Value Added Tax (“VAT”) that will be recovered in due course.

Inventories ended at $171,520 which was an increase of $31,690, as compared to the level reported at December 31, 2013. As reported at the end of the second quarter, our inventories have increased as a result of abnormal customer purchasing activities following poor weather, reduced pest pressure in some of our key markets, the reduction in peanuts and cotton acres and the importance of crop commodity price on growers’ decisions. It is important to note that our inventories are down 2% in comparison to June 30, 2014 partly as a result of holding back manufacturing output. We believe our inventories are stated at the lower of cost or market.

The deferred revenues at December 31, 2013 were fully realized at September 30, 2014. During the three month period ended September 30, 2014, the Company reduced deferred revenues generated in the second quarter of 2014. These are primarily related to prepaid orders for our propriety delivery systems. Finally, as the Company has built momentum for the 2015 growing season, prepaid expenses and other assets increased by $5,237, driven by our continued investment in SmartBox equipment to respond to market acceptance of our delivery system technology. Offsetting this increase, as we continue to hold back manufacturing activity, -and accounts payable decreased by $22,341. Furthermore, the Company reduced its income tax receivable by $7,937 following the filing of our 2013 federal and state tax returns and receipt of tax overpayments.

The Company accrues programs in line with the growing season upon which specific products are targeted. Typically crop products have a growing season that ends on September 30 each year. During the nine months ended September 30, 2014, the Company made accruals in the amount of $36,080. Programs are primarily paid out to customers either in the final quarter of the fiscal year or the first quarter of the next fiscal year. During the nine months ending September 30, 2014, the Company made payments in the amount of $16,920. During the nine months to the end of September 30, 2013, the Company accrued $74,674 and made payments in the amount of $9,795.

The Company used $5,947 in investing activities during the nine months ended September 30, 2014, primarily to expand manufacturing capacity in response to demand for certain core products. During the nine months ended September 30, 2013, the Company invested $12,290 on fixed assets (primarily in the manufacturing facility) and made a $3,687 equity investment in TyraTech Inc., a natural life science company.

Financing activities used $38,477 during the nine months ended September 30, 2014, compared to $17,223 in the same period of the prior year. This included the take up of additional debt under the revolving credit line and deferred payments on notes related to product acquisitions. The Company made dividend payments in the amount of $4,251, as compared to $3,390 in the same period of last year. Finally, the Company received $1,616 from the exercise of stock options and the sale of common stock under its Employee Stock Purchase Plan (including associated tax benefits), as compared to $929 for the same period last year.

The Company has a revolving line of credit and a note payable that together constitute the short-term and long-term loan balances shown in the balance sheets at September 30, 2014 and December 31, 2013. These are summarized in the following table:

| Indebtedness $000’s | September 30, 2014 Long- term | Short- term | Total | December 31, 2013 Long- term | Short- term | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revolving line of credit | $95,000 | $— | $95,000 | $51,550 | $— | $51,550 |
| Notes payable | 73 | 71 | 144 | 126 | 69 | 195 |
| Total Indebtedness | $95,073 | $71 | $95,144 | $51,676 | $69 | $51,745 |

The Company has three key covenants under its senior credit facility. The covenants are as follows: The Company must (1) maintain its borrowings below a certain consolidated funded debt ratio, (2) limit its annual spending on the acquisition of fixed asset capital additions, and (3) maintain a certain consolidated fixed charge coverage ratio. As of September 30, 2014, the Company was in compliance with all covenants. On July 18, 2014, the senior credit facility agreement was amended. See Note 8 of the Notes to Condensed Consolidated Financial Statements.

At September 30, 2014, based on its performance against the most restrictive covenants listed above, the Company had the capacity to increase its borrowings by up to $51,156.

We believe that anticipated cash flow from operations, existing cash balances and available borrowings under our senior credit facility will be sufficient to provide us with liquidity necessary to fund our working capital and cash requirements for the next twelve months.

### RECENTLY ISSUED ACCOUNTING GUIDANCE

In August 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-15, *Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.* This ASU requires that management of an entity assesses whether there is substantial doubt about the ability of the entity to continue as a going concern and for making the appropriate disclosures. The assessment must be performed at each annual and interim reporting period, and there is substantial doubt about an entity’s ability to continue as a going concern if it is probable that the entity will be unable to meet its obligation as they become due within 12 months of the date of the financial statements are issued. In the assessment, management must consider the information available at the date of issuance of the financial statements, as well as mitigating factors and plans to alleviate the substantial doubt. ASU 2014-15 is effective for annual period ending after December 15, 2016 and interim periods thereafter.

In June 2014, FASB issued ASU 2014-12, *Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, a consensus of the FASB Emerging Issues Task Force*. ASU 2014-12 requires that a performance target that affects vesting of share-based payment awards and that could be achieved after the requisite service period be treated as a performance condition. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the periods for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible to vest in the award if the performance target is achieved. ASU 2014-12 is effective for all entities for interim and annual periods beginning after December 15, 2015, with early adoption permitted. An entity may apply the amendments in ASU 2014-12 either (i) prospectively to all awards granted or modified after the effective date or (ii) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The adoption of ASU 2014-12 is not expected to have a material impact on the Company’s consolidated financial condition or results of operations.

In May 2014, the FASB issued ASU 2014-09, *Revenue from Contracts with Customers*. ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017 or its impact on our consolidated financial statements.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The Company continually re-assesses the critical accounting policies used in preparing its financial statements for inclusion in the AVD published financial statements. In the Company’s condensed consolidated Form 10-K for the financial year ended December 31, 2013, the Company provided a comprehensive statement of critical accounting policies. These policies have been reviewed in detail as part of the preparation work for this Form 10-Q. All the policies listed in the Company’s Form 10-K for the year ended December 31, 2013 remain valid and are hereby incorporated by reference.

## Market risk

As filed, 1,409 characters.

The Company is exposed to market risk related to changes in interest rates, primarily from its borrowing activities. The Company’s indebtedness to its primary lender is evidenced by a line of credit with a variable rate of interest, which fluctuates with changes in the lender’s reference rate. For more information, please refer to the applicable disclosures in the Company’s Form 10-K filed with the SEC for the year ended December 31, 2013. The Company uses derivative financial instruments for trading purposes to protect trading performance from exchange rate fluctuations on material contracts.

The Company conducts business in various foreign currencies, primarily in Europe, Mexico, Central and South America. Therefore changes in the value of the currencies of such countries or regions affect the Company’s financial position and cash flows when translated into U.S. Dollars. The Company has mitigated and will continue to mitigate a portion of its currency exchange exposure through natural hedges based on the operation of decentralized foreign operating companies in which the majority of all costs are local-currency based. Furthermore, the Company has established a procedure for covering forward exchange rates on specific purchase orders when appropriate. A 10% change in the value of all foreign currencies would have an immaterial effect on the Company’s financial position and cash flows.

## Controls and procedures

As filed, 1,078 characters.

As of September 30, 2014, the Company has established a comprehensive set of disclosure controls and procedures designed to ensure that all information required to be disclosed in its filings under the Securities Exchange Act (1934) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. As of September 30, 2014, the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, has concluded, based on their evaluation, that the Company’s disclosure controls and procedures are effective to provide reasonable assurance of the achievement of the objectives described above.

There were no changes in the Company’s internal controls over financial reporting that occurred during the most recent quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

### PART II. OTHER INFORMATION

The Company was not required to report any matters or changes for any items of Part II except as disclosed below.

## Risk factors

As filed, 2,021 characters.

The Company continually re-assesses the business risks, and as part of that process detailed a range of risk factors in the disclosures in AVD’s Report on Form 10-K for the fiscal year ended December 31, 2013, filed on February 28, 2014. In preparing this document, we have reviewed all the risk factors included in that document and find that there are no material changes to those risk factors other than as follows:

**Higher than normal levels of inventory may lead to continued, decreased profitability.** The Company manufactures more than half of its products, including the majority of its corn soil insecticides which, in years of strong financial performance, have comprised a significant portion of our consolidated net sales. Reduced use of the Company’s corn products in 2013 and reduced sales of those products in 2014 have led to higher-than-normal inventory levels at the Company. In the interest of reducing excess inventory, the Company has decreased manufacturing activity at its facilities; this has had the effect of decreasing the Company’s absorbed manufacturing costs and thereby the Company’s profitability. If demand for these products does not increase, then the attendant under absorption of manufacturing costs will continue to affect the Company’s profitability adversely. There is no guarantee that the Company will be able to reduce its inventory levels materially, increase plant activity or return to greater profitability.

**Corn commodity prices may affect the Company’s financial performance.** The Company’s corn products are an important element of its overall financial performance. To the extent that corn commodity prices decline and/or the ratio of other crop prices (such as soybeans) to corn prices increases, growers may either cut back on crop inputs, plant less corn, plant other crops in lieu of corn or plant nothing. Any one or all of these decisions may have the effect of reducing the sales of the Company’s corn products and, consequently, its financial performance.

Filed Oct 31, 2014.
Source: SEC EDGAR, the filing index for accession 0001193125-14-391725. Last ingested by Listed: Nov 11, 2026, 00:16 ET. No prices; not investment advice.
